Author:
Brandl Christian,Haas Cornelia,d’Argouges Sandrine,Fisch Tanja,Kufer Peter,Brischwein Klaus,Prang Nadja,Bargou Ralf,Suzich JoAnn,Baeuerle Patrick A.,Hofmeister Robert
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference40 articles.
1. Abrams SI (2005) Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response. Front Biosci 10:809–821
2. Balaji KN, Schaschke N, Machleidt W, Catalfamo M, Henkart PA (2002) Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 196:493–503
3. Bargou R, Kufer P, Kirchinger P, Noppeney R, Schuler M, Viardot A, Weigang-Koehler K, Zettl F, Gerecke C, Libicher M, Einsele H, Riethmuller G, Lutterbuese R, Klinger M, Baeuerle PA, Schlereth B, Reinhardt C (2006) MT103 (anti-CD19 × anti-CD3-BiTE) induces B cell depletion, clearance of bone marrow infiltration and clinical responses in heavily pre-treated NHL patients: first data from dose-escalation study MT103-104. In: 11th congress of European hematology association. Ref type: Abstract
4. Blank C, Brown I, Peterson AC, Spiotto M, Iwai Y, Honjo T, Gajewski TF (2004) PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res 64:1140–1145
5. Brischwein K, Schlereth B, Guller B, Steiger C, Wolf A, Lutterbuese R, Offner S, Locher M, Urbig T, Raum T, Kleindienst P, Wimberger P, Kimmig R, Fichtner I, Kufer P, Hofmeister R, da Silva AJ, Baeuerle PA (2006) MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors. Mol Immunol 43:1129–1143
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献